|
|
 |
|
Viewing report
|
|
 |
 |
Cardiac Markers - Making their Mark on the Medicines Market
Datamonitor, Jan 2002
This brief sets out to: * Review the available diagnostic markers for cardiac ischemia, atherosclerotic disease, heart failure, and platelet function. The four classes of cardiac markers are presented in order of their respective market size, with ischemia markers representing the largest market, and markers of platelet function the smallest. * Analyze each class of marker with respect to accuracy, convenience, usefulness, cost, and inherent shortcomings and/or limitations, and provide a rating for each class based on these parameters * consider the commercial implications of each class of cardiac marker, including the likely impact(s) on the existing CV diagnostics and therapeutics markets * discuss the future role of genetic analysis in shaping the diagnostics and therapeutics markets, with attention paid to genetic markers currently under investigation.
Customers who bought this item also bought
2004 U.S. Hospital Point-of-Care Cardiac Marker Survey
Emerging Diagnostic Markers in Alzheimers Disease
Cardiac Marker Diagnostic Testing Markets
Emerging Technologies in Cardiovascular Diagnostic Imaging: The Future of Cardiac MRI and Echocardiography
2004 U.S. Hospital Point-of-Care Survey Report
Cardiac Rhythm Management Devices World Markets
Analysis on Anti-cold Medicines in Recent Three Years
Market Report of Medicines for Hypertension Prevention and Cure
|
 |
|
|